Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PIRARUBICIN for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 175 adverse event reports in the FDA FAERS database where PIRARUBICIN was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for PIRARUBICIN

Side Effect Reports % Deaths Hosp.
Myelosuppression 408 30.3% 5 260
White blood cell count decreased 207 15.4% 9 114
Neutrophil count decreased 145 10.8% 3 90
Bone marrow failure 127 9.4% 14 55
Nausea 111 8.2% 2 68
Vomiting 104 7.7% 2 70
Gastrointestinal disorder 58 4.3% 1 39
Leukopenia 55 4.1% 0 21
Pyrexia 55 4.1% 4 36
Neutropenia 54 4.0% 13 18
Febrile neutropenia 53 3.9% 13 16
Decreased appetite 50 3.7% 7 20
Platelet count decreased 43 3.2% 6 21
Anaemia 42 3.1% 6 13
Hepatic function abnormal 41 3.0% 3 11

Other Indications for PIRARUBICIN

Breast cancer female (271) Chemotherapy (135) Breast cancer (82) Lymphoma (68) Invasive ductal breast carcinoma (56) Acute lymphocytic leukaemia (51) Non-hodgkin's lymphoma (40) Neoplasm (38) B-cell lymphoma (36) Neoplasm malignant (34)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

PIRARUBICIN Full Profile All Diffuse large b-cell lymphoma Drugs PIRARUBICIN Demographics PIRARUBICIN Timeline